У нас вы можете посмотреть бесплатно Cannabis stocks may be relighting in 2020 или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
CNBC's Frank Holland reports on the cannabis comeback. With CNBC's Brian Sullivan and the Fast Money traders, Tim Seymour, Brian Kelly, Karen Finerman and Guy Adami. “I think this is going to be a big year for cannabis ETFs,” said Dave Nadig, managing director of ETF.com. “It’s been a rough year for most of the cannabis investments, and I think that in 2020, we’re going to see a continued push towards legalization around the world.” The ETFMG Alternative Harvest ETF (MJ), the market’s largest cannabis ETF in terms of assets under management, has shed nearly 31% in value year to date as many of its underlying securities went through an industrywide reckoning related to longer-than-anticipated product rollouts and overly enthusiastic forward estimates. Rival marijuana ETFs launched earlier this year have shared in the pain. “The companies that are in these funds right now, I think, are going to get overpriced very quickly and we’re going to see a lot more companies come to play,” Nadig said. Tim Seymour, who is founder and chief investment officer of Seymour Asset Management and runs the Amplify Seymour Cannabis ETF (CNBS), advised investors to take their time if they’re considering buying into the downtrodden group. “As a guy who runs a cannabis ETF … my view is that the size of the addressable market has grown,” Seymour said shortly after returning from the MJBizCon cannabis business conference in Las Vegas. “You’re starting to see separation of the performers and the nonperformers. You’re starting to see capital markets dynamics come to work,” Seymour said. “So, there’s no question about the efficacy [or] what’s happening in the sector. The question is are these companies, right now, you can invest in?” For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://www.cnbc.com/pro/?__source=yo... » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC » Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide. Connect with CNBC News Online Get the latest news: http://www.cnbc.com/ Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC Follow CNBC News on Facebook: Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC #CNBC #CNBC TV https://www.cnbc.com/pro/?__source=yo... » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC » Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide. Connect with CNBC News Online Get the latest news: http://www.cnbc.com/ Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC Follow CNBC News on Facebook: Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC #CNBC #CNBC TV